Thurston Springer Miller Herd & Titak’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$93.6K	Buy	1,356 +428	+46%	+$29.5K	0.01%	521
2025 Q1	$64.5K	Buy	928 +143	+18%	+$9.94K	0.01%	556
2024 Q4	$67.6K	Buy	785 +271	+53%	+$23.3K	0.01%	462
2024 Q3	$61.3K	Buy	514 +61	+13%	+$7.27K	0.02%	512
2024 Q2	$64.7K	Buy	+453	New	+$64.7K	0.02%	503